Module 9: Patient Care Procedures California Community Colleges
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Improving the Quality of Life of the Elderly and Disabled
IMPROVING THE QUALITY OF LIFE OF THE ELDERLY AND DISABLED PEOPLE IN HUMAN SETTLEMENTS IMPROVING THE QUALITY OF LIFE OF ELDERLY AND DISABLED PEOPLE IN HUMAN SETTLEMENTS VOLUME I A Resource Book of Policy and Programmes from around the World United Nations Centre for Human Settlements (Habitat) Nairobi, 1993 HS/284/93E ISBN 92-1-131208-6 FOREWORD The world's population is ageing dramatically. The total number of people aged 60 and older grew from 200 million in 1950 to 400 million in 1982. Their number is expected to increase to 600 million in the year 2001 when 70 per cent of them will live in developing countries. This demographic revolution has major consequences on the way human settlements are designed, managed and used. The United Nations and its agencies have undertaken many activities that recognize this reality. The General Assembly adopted the World Programme of Action concerning Disabled Persons and proclaimed 1981 the International Year of Disabled Persons. In 1982, 124 Member States adopted the International Plan of Action on Aging at the World Assembly on Aging. These two landmark events launched a variety of activities and studies during the United Nations Decade of Elderly and Disabled Persons. The United Nations Centre for Human Settlements (Habitat) launched the decade with two important documents. Designing with Care - a Guide to Adaptation of the Built Environment for Disabled Persons was published as the result of cooperation between the United Nations, UNCHS (Habitat) and the Swedish International Development Agency (SIDA). This guide pointed out that implementation of suggested design guidelines and related policies and programmes would have to be undertaken by authorities, taking into consideration the economic, social and climatic conditions of the human settlement concerned. -
Clinical Policy: Hyperemesis Gravidarum Treatment Reference Number: PA.CP.MP.34 Effective Date: 01/18 Coding Implications Last Review Date: 04/18 Revision Log
Clinical Policy: Hyperemesis Gravidarum Treatment Reference Number: PA.CP.MP.34 Effective Date: 01/18 Coding Implications Last Review Date: 04/18 Revision Log Description Hyperemesis gravidarum is a term reserved to describe the most severe cases of nausea and vomiting in pregnancy (NVP). It results from severe nausea and vomiting, and the resultant inability to rehydrate and replenish nutritional reserves. A diagnosis of hyperemesis gravidarum is best made when it is based on objective findings such as moderate to large ketonuria and weight loss. Weight loss of 5% or greater is often described as diagnostic of hyperemesis gravidarum but this is not to suggest that measures to improve nausea and vomiting should not be undertaken prior to this. Hyperemesis gravidarum tends to begin earlier in pregnancy and last longer than those patients with less severe NVP. When the step-approach algorithm does not allow for continued adequate hydration of the patient, intravenous (IV) infusion or subcutaneous (SQ) micropump infusion of metoclopramide or ondansetron can allow for treatment until the patient can reliably take oral medications. The ability to perform activities of daily living, tolerate most food intake, and take oral medications are measures that objectively and subjectively instruct the practitioner as to the value of these therapies. When these therapies have allowed the patient to return to the above states of function, they can be discontinued. Oral therapies can be used in conjunction with IV and SQ infusion if tolerated. There is not a place for continuous, long-term IV or SQ infusion of medications to manage hyperemesis if the patient is functioning as described above. -
Errors Associated with Oxytocin
February 2020 Volume 18 Issue 2 Now Available from ISMP Errors associated with oxytocin use: A multi- Expanded Smart Pump Guidelines organization analysis by ISMP and ISMP Canada We have just released revised and expanded Guidelines for Optimizing Safe ntravenous (IV) oxytocin used antepartum is indicated to induce labor in patients Implementation and Use of Smart Infusion with a medical indication, to stimulate or reinforce labor in selected cases of uterine Pumps to provide strategies for address - Iinertia, and as an adjunct in the management of incomplete or inevitable abortion. ing potential barriers and integrating this Used postpartum, IV oxytocin is indicated to produce uterine contractions during technology with other electronic systems. expulsion of the placenta and to control postpartum bleeding or hemorrhage. However, The expanded guidelines cover a broad improper administration of oxytocin can cause hyperstimulation of the uterus, which in scope of smart infusion pump usage in turn can result in fetal distress, the need for an emergency cesarean section, or uterine both inpatient and ambulatory settings, rupture. Sadly, a few maternal, fetal, and neonatal deaths have been reported. including perioperative, procedural, and radiology locations. The expanded guide - In October 2019, ISMP Canada published a multi-incident analysis 1 to identify oppor - lines also include recommendations to tunities to improve the safe use of this high-alert medication. A total of 144 reports of employ smart infusion pumps with dose incidents associated with oxytocin were analyzed from voluntary reports submitted error-reduction systems for plain IV fluid to ISMP Canada and the Canadian National System for Incident Reporting (NSIR) infusions. -
I Used to Smoke Menthol Cigarettes. There Was Something About The
In response to the scent of the soap I used to smoke menthol cigarettes. There was something about the Alice Hattrick combination of smoke, produced by fire, and menthol, a chemical in every kind of mint that tricks your brain into thinking it’s tasting something cold, that was so appealing. Alcohol is still the active ingredient in mouthwash but it is nearly always flavoured mint. Listerine was developed by the doctors who founded Johnson & Johnson after Jospeh Lister became the first person to conduct a surgical procedure in sterilised conditions. In the 16th century, a number of herbs were used to clean the mouth and teeth, mint but also sage and rosemary in vinegar, alongside practical solutions like wine, which replaced urine (containing ammonia) as a popular disinfectant. In the 20th century, mint became the predominant flavour of mouthwash and toothpaste because it was widely available and made the mouth cool, counteracting the fiery sensation of astringent products. When menthol binds with a particular receptor in our brains – TRPM8 – it has the same effect as exposing it to cool temperatures. It’s the menthol that makes it feel like it’s working. There aren’t many perfumes that smell predominantly of mint, but they do exist. Aqua Allegoria Herba Fresca by Guerlain (1999) smells uber clean, like actual hygiene: mint gum, and then lemon and grass as the mint fades like a… mint? Apparently, Jean-Paul Guerlain wanted to evoke the memory of playing barefoot in the grass as a child, crushing mint leaves underfoot, which is probably why this smells like the kind of green you imagine, but have never actually experienced. -
Clinical Efficacy in Reducing Dentin Hypersensitivity of a Dentifrice
Clinical Efficacy in Reducing Dentin Hypersensitivity of a Dentifrice Containing 8.0% Arginine, Calcium Carbonate, and 1450 ppm Fluoride Compared to a Dentifrice Containing 8% Strontium Acetate and 1040 ppm Fluoride Under Consumer Usage Conditions Before and After Switch-Over T. Schiff, DMD Scottsdale Center for Dentistry San Francisco, CA, USA L.R. Mateo, MA LRM Statistical Consulting Hoboken, NJ, USA E. Delgado, DDS, MSc D. Cummins, PhD Y.P. Zhang, PhD, DDS (Hon) W. DeVizio, DMD Colgate-Palmolive Technology Center Piscataway, NJ, USA Abstract • Objective: The objective of this 16-week, double-blind, randomized, switch-over design study was to compare the efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride as sodium monofluorophosphate (Colgate ® Sensitive Pro-Relie f ™ [also marketed as elmex ® Sensitive Professional ™]) to a desensitizing den - tifrice containing 8% strontium acetate and 1040 ppm fluoride as sodium fluoride (Sensodyne ® Rapid Relief) under relevant con - sumer usage conditions. • Methods: Qualifying subjects from the San Francisco, CA, USA area, who presented two hypersensitive teeth with a tactile hyper - sensitivity score (Yeaple Probe) between 10 and 50 grams of force and an air blast hypersensitivity score of 2 or 3 (Schiff Cold Air Sensitivity Scale), participated in this two-phase double-blind study. Subjects were randomly assigned to one of two test groups. The first phase of the study consisted of twice-daily at-home brushing with the first assigned dentifrice for eight weeks. The second phase of the study consisted of switching product use to the second assigned dentifrice for a second eight-week period. -
Pro-Argin, a Breakthrough Technology Based Upon Arginine
American Journal of Dentistry, Vol. 22, Special Issue A, March, 2009 A, March, 22, Special Issue Vol. American Journal of Dentistry, Vol. 22, Special Issue A, March, 2009 - p. 1A - 24A Introducing Pro-Argin™ A Breakthrough Technology Based upon Arginine and Calcium for In-Office Treatment of Dentin Hypersensitivity _______________________________________________________________________________________________________________________________________________________________ Editorial _______________________________________________________________________________________________________________________________________________________________ Dentin hypersensitivity: Beneficial effects of an arginine-calcium carbonate desensitizing paste Dentin hypersensitivity is a common occurrence diately after dental scaling procedures and its and is often a chief concern among patients. The sustained relief over 4 weeks. Another paper pre- pain associated with dentin hypersensitivity is sents the results of a double-blind, stratified, caused by some type of external stimulus and the randomized clinical study showing the successful sensitivity can range in its intensity from patient to desensitizing effect of the 8% arginine-calcium patient. The successful management of dentin carbonate paste tested, when applied as a pre- hypersensitivity is often very challenging for the procedure to professional dental cleaning. dental professional. The cause of the pain and the This Special Issue also includes a study con- description of the discomfort reported by -
DOCUMENT RESUME Essential Skills for the Care Team. A
DOCUMENT RESUME ED 419 937 CE 076 574 TITLE Essential Skills for the Care Team. A Program for New Employees in Residential and Home Care. INSTITUTION State Univ. of New York, Albany. Rockefeller Coll.; Eddy/Northeast Health, Troy, NY. SPONS AGENCY Office of Vocational and Adult Education (ED), Washington, DC. National Workplace Literacy Program. PUB DATE 1998-00-00 NOTE 456p.; For a related document, see CE 076 575. CONTRACT V198A40098-96 PUB TYPE GuideS Classroom Teacher (052) EDRS PRICE MF01/PC19 Plus Postage. DESCRIPTORS Adult Basic Education; Allied Health Occupations Education; Classroom Techniques; Competence; Competency Based Education; *Home Health Aides; *Nurses Aides; *On the Job Training; Postsecondary Education; Teaching Methods; Units of Study; *Workplace Literacy ABSTRACT This document contains modules for two types of training. It provides 20 hours of training to newly hired Nursing Assistant Trainees (NATs) in residential care settings preparing to become state Certified Nursing Assistants (CNAs), using eight stand-alone modules supported by training process guides. It also includes 7 hours of training for newly hired NATs in the home care settings preparing to become state certified Home Health Aides (HHAs), using five stand-alone modules with training process guides. The materials are suitable for workplace literacy programs for adults with low levels of English literacy skills. A learning strategies module serves as an introduction to both programs. The CNA program contains the following modules: understanding your -
Reinvigorating and Nourishing
Complete Line of Personal Care Products Reorder No. Description Quantity 1386 Body Wash & Conditioner, 8fl. oz. 48/Cs 1387 Body Wash & Conditioner, 1 Gallon 4/Cs 1390 Hand and Body Lotion, 4fl. oz. 96/Cs 1391 Hand and Body Lotion, 8fl. oz. 48/Cs Reinvigorating 1392 Hand and Body Lotion, 1 Gallon 4/Cs 1393 All Purpose Lotion Soap, 8fl. oz. 48/Cs and Nourishing 1394 All Purpose Lotion Soap, 1 Gallon 4/Cs 1396 Tearless Baby Shampoo, 12fl. oz. 12/Cs Pamper yourself with Dynarex's complete line 4848 Mint Flavored Mouthwash, 4fl. oz. 96/Cs of personal care products. Our products are 4849 Mint Flavored Mouthwash, 16fl. oz. 12/Cs formulated with the finest quality ingredients 4881 Adult Hairbrushes-Bone 12/24/Cs to provide the very best in personal care for children to adults. From lotions, mouthwash, 4882 Adult Combs 5" black 180/12/Cs shampoos and cleansers, look and feel your 4847 Roll-on-Deodorant 1.5 fl. oz. 96/Cs best with our complete Personal Care Line! 4891 Fingernail Clipper 24/24/Cs 4844 Baby Oil - 12 fl oz 24/Cs 4874 Baby Powder - 4 oz 48/Cs Find us on: Already mobile? Scan your smart phone For more information contact your here for more local Dynarex® distributor sales representative. information. Or call 888-396-2739 to find your nearest distributor. Dynarex • 10 Glenshaw Street • Orangeburg, NY 10962 • www.dynarex.com © 2014 Dynarex Corporation r0 Dynarex Body Wash & Conditioner Body and Shampoo A rich, skin-conditioning botanical cleanser for the entire body. This soap-free gel with a nourishing lather delivers all-over cleansing and helps moisturize to leave skin feeling soft and silky. -
A Portable Mechanical Pump Providing Over Four Days of Patient-Controlled Analgesia by Perineural Infusion at Home
A Portable Mechanical Pump Providing Over Four Days of Patient-Controlled Analgesia by Perineural Infusion at Home Brian M. Ilfeld, M.D., and F. Kayser Enneking, M.D. Background and Objectives: Local anesthetics infused via perineural catheters postoperatively decrease opioid use and side effects while improving analgesia. However, the infusion pumps described for outpatients have been limited by several factors, including the following: limited local anesthetic reservoir volume, fixed infusion rate, and inability to provide patient-controlled doses of local anesthetic in combination with a continuous infusion. We describe a patient undergoing open rotator cuff repair who was discharged home with an interscalene perineural catheter and a mechanical infusion pump that allowed a variable rate of continuous infusion, as well as patient-controlled boluses of local anesthetic for over 4 days. Case Report: A 77-year-old woman, who had previously required a 3-day hospital admission for acute postoperative pain following an open repair of her left rotator cuff, presented for an open repair of her contralateral rotator cuff. Preoperatively she received an interscalene block and perineural catheter. After the procedure she was discharged home with a portable pump that infused ropivacaine continuously at a rate of 6 mL/h and allowed a 2-mL patient-controlled bolus every 20 minutes (550-mL reservoir). The basal infusion was decreased, as tolerated, by having the patient reprogram the pump with instructions given over the telephone. Without the use of any oral opioids, the patient scored her surgical pain 0 to 1 (on a scale of 0 to 10) while at rest and 2 to 3 for 2 physical therapy sessions during which she used the bolus function to reinforce her analgesia. -
Tumor Registrar Vocabulary: the Composition of Medical Terms Book Three
SEER Program Self InstructionalManual for Cancer Registrars Tumor Registrar Vocabulary: The Composition of Medical Terms Book Three Second Edition U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National institutesof Health SEER PROGRAM SELF-INSTRUCTIONAL MANUAL FOR CANCER REGISWRARS Book 3 - CANCER REGISTRAR VOCABULARY: THE COMPOSITION OF MEDICAL TERMS Second Edition Originally Preparedfor the Louisiana Regional Medical Program Under the Direction of: C. Dennis Fink, Ph.D., Program Director, HumRRO Robert F. Ryan, M.D., Technical Advisor, Tulane University Revised by: SEER Program Cancer Statistics Branch, National Cancer Institute Editor-in-Chief: Evelyn M. Shambaugh, M.A., CTR Cancer Statistics Branch, National Cancer Institute Assisted by Self-InstructionalManual Committee: Dr. Robert F. Ryan, EmeritusProfessor of Surgery Tulane University School of Medicine New Orleans, Louisiana Mildred Weiss Ruth Navotny Mary A. Kruse LOs Angeles, California San Francisco, California Bethesda, Maryland BOOK 3 CANCER REGISTRAR VOCABULARY: THE COMPOSITION OF MEDICAL TERMS TABLE OF CONTENTS BOOK 3: CANCER REGISTRAR VOCABULARY: THE COMPOSITION OF MEDICAL TERMS Page Section A--Objectives and Content of Book 3 ................................... 1 Section B--Word Roots, Suffixes, and Prefixes ................................... 5 Section C--Common Symptomatic Suffixes ..................................... 31 Section D--Common Diagnostic Suffixes ....................................... 63 Section E--Cancer Registrar Vocabulary: Complaints -
ACR Manual on Contrast Media
ACR Manual On Contrast Media 2021 ACR Committee on Drugs and Contrast Media Preface 2 ACR Manual on Contrast Media 2021 ACR Committee on Drugs and Contrast Media © Copyright 2021 American College of Radiology ISBN: 978-1-55903-012-0 TABLE OF CONTENTS Topic Page 1. Preface 1 2. Version History 2 3. Introduction 4 4. Patient Selection and Preparation Strategies Before Contrast 5 Medium Administration 5. Fasting Prior to Intravascular Contrast Media Administration 14 6. Safe Injection of Contrast Media 15 7. Extravasation of Contrast Media 18 8. Allergic-Like And Physiologic Reactions to Intravascular 22 Iodinated Contrast Media 9. Contrast Media Warming 29 10. Contrast-Associated Acute Kidney Injury and Contrast 33 Induced Acute Kidney Injury in Adults 11. Metformin 45 12. Contrast Media in Children 48 13. Gastrointestinal (GI) Contrast Media in Adults: Indications and 57 Guidelines 14. ACR–ASNR Position Statement On the Use of Gadolinium 78 Contrast Agents 15. Adverse Reactions To Gadolinium-Based Contrast Media 79 16. Nephrogenic Systemic Fibrosis (NSF) 83 17. Ultrasound Contrast Media 92 18. Treatment of Contrast Reactions 95 19. Administration of Contrast Media to Pregnant or Potentially 97 Pregnant Patients 20. Administration of Contrast Media to Women Who are Breast- 101 Feeding Table 1 – Categories Of Acute Reactions 103 Table 2 – Treatment Of Acute Reactions To Contrast Media In 105 Children Table 3 – Management Of Acute Reactions To Contrast Media In 114 Adults Table 4 – Equipment For Contrast Reaction Kits In Radiology 122 Appendix A – Contrast Media Specifications 124 PREFACE This edition of the ACR Manual on Contrast Media replaces all earlier editions. -
Performance Drug List - Standard Control
October 2020 Performance Drug List - Standard Control The CVS Caremark® Performance Drug List - Standard Control is a guide within select therapeutic categories for clients, plan members and health care providers. Generics should be considered the first line of prescribing. If there is no generic available, there may be more than one brand-name medicine to treat a condition. These preferred brand-name medicines are listed to help identify products that are clinically appropriate and cost-effective. Generics listed in therapeutic categories are for representational purposes only. This is not an all-inclusive list. This list represents brand products in CAPS, branded generics in upper- and lowercase Italics, and generic products in lowercase italics. PLAN MEMBER HEALTH CARE PROVIDER Your benefit plan provides you with a prescription benefit program Your patient is covered under a prescription benefit plan administered by CVS Caremark. Ask your doctor to consider administered by CVS Caremark. As a way to help manage health prescribing, when medically appropriate, a preferred medicine from care costs, authorize generic substitution whenever possible. If you this list. Take this list along when you or a covered family member believe a brand-name product is necessary, consider prescribing a sees a doctor. brand name on this list. Please note: Please note: • Your specific prescription benefit plan design may not cover • Generics should be considered the first line of prescribing. certain products or categories, regardless of their appearance in • The member's prescription benefit plan design may alter this document. Products recently approved by the U.S. Food 1 and Drug Administration (FDA) may not be covered upon coverage of certain products or vary copay amounts based on release to the market.